To receive important alerts and updates from Gold Coast Primary Health Network, please submit the form below.
To receive important alerts and updates from Gold Coast Primary Health Network, please submit the form below.
Immunisations are a safe and effective way to protect you, your family and vulnerable people in the community from serious diseases. When you get vaccinated, you contribute to the increase of the overall level of immunity in the population and thus minimising the spread of infection. This concept is known as ‘herd immunity’ and means that enough people have immunity to stop the spread of disease which protects people who can’t be vaccinated.
Immunisation is a way of protecting against serious diseases. Once we’ve been immunised, our bodies are better able to fight these diseases if we come into contact with them.
Thanks to government-funded Australian vaccination programs, diseases like tetanus, diphtheria, and polio are now extremely rare. The Australian Academy of Science provides easy-to-understand information on immunisation, helping you make informed health decisions. Visit the Australian Institute of Health and Welfare (AIHW) and Sharing Knowledge About Immunisation for resources and factsheets on vaccine-preventable diseases.
Respiratory Syncytial Virus (RSV) vaccine and monoclonal antibodies
The Queensland Paediatric Respiratory Syncytial Virus Prevention Program expanded on 1 December 2024. This expanded program provides free Respiratory Syncytial Virus (RSV) immunisation during pregnancy and to eligible infants and young children living in Queensland.
RSV vaccine recommendations and funding:
Population recommended for vaccine | Vaccine OR monoclonal antibody | Funding |
Pregnant women to protect their newborn
infant from 28 and 36 weeks gestation to protect infants against severe RSV disease from birth for up to 6 months. |
Abrysvo only – (vaccine) | NIP funded |
infants and young children can receive a long-acting monoclonal antibody that provides protection against severe RSV disease for at least 5 months from administration. | Nirsevimab (brand name Beyfortus®) – (monoclonal antibody) | QLD funded*
|
All people aged ≥75 years | Abrysvo or Arexvy – (vaccine) | Private purchase |
Aboriginal and Torres Strait Islander people
aged ≥60 years |
Abrysvo or Arexvy – (vaccine) | Private purchase |
People with medical risk factors for severe
RSV disease aged ≥60 years. |
Abrysvo or Arexvy – (vaccine) | Private purchase |
* Funded for residents of QLD only
Further Information:
So we can provide you with the most accurate information,
please tell us a little more about yourself